Garlic has a long history in traditional medicine, but evidence for its benefits varies by preparation, and patients taking medications that increase bleeding risk should use it with caution.
|Articles|July 29, 2022
Daily OTC Pearl: L-Lysine
Author(s)Saro Arakelians, PharmD
L-Lysine is a protein source that supports collagen synthesis.
Advertisement
OTC/Lifestyle Pearl of the Day: L-Lysine
Indication: L-Lysine is a protein source that supports collagen synthesis.
Insight:
- L-Lysine (from L-Lysine monohydrochloride) 1.0 g (1000 mg).
- Other Ingredients: Cellulose, croscarmellose sodium, silica, magnesium stearate (vegetable source), stearic acid (vegetable source) and vegetable coating. Contains no sugar, salt, starch, yeast, wheat, gluten, corn, soy, milk, egg, shellfish, or preservatives.
- Store in a cool, dry place.
- Directions: As a dietary supplement, take 1 tablet on an empty stomach 1 to 2 times daily, as needed.
Source:
Advertisement
Related to this article
From survodutide titration to oral PCSK9 adherence and HF care models, AHA 2026 experts pointed to pharmacists as key to putting new data into practice.
Christie Ballantyne, MD, says high extension enrollment and a single 20-mg daily dose are encouraging signs for patient adherence to oral enlicitide.
An ASRA-recognized quality improvement project draws attention to injectate reproducibility, offering a starting point for examining medication preparation and pharmacists’ role in safer pain procedures.
A meta-analysis presented at IDWeek 2026 found responses were stronger after chemotherapy but waned within a year, supporting a 2-dose strategy.
How should a factor XIa inhibitor be incorporated into secondary stroke prevention?
Inconsistent state immunization laws complicate pharmacy operations and limit patient access.
Pharmacists can strengthen opioid safety through individualized counseling, overdose prevention, and coordinated follow-up that keeps patients involved in treatment decisions.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Reportedly Shelves Commissioner's National Priority Voucher Program
2
Glucose Monitoring: Timing Makes Every Reading Count
3
Belantamab Mafodotin Moves Into Lenalidomide-Refractory Myeloma in Updated NCCN Guidelines
4
Inside the OCEANIC-STROKE Trial and What Asundexian Means for the Future of Stroke Prevention
5